Compare DCTH & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | GCO |
|---|---|---|
| Founded | 1988 | 1924 |
| Country | United States | United States |
| Employees | 156 | N/A |
| Industry | Medical/Dental Instruments | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 372.5M | 432.0M |
| IPO Year | 2015 | 1994 |
| Metric | DCTH | GCO |
|---|---|---|
| Price | $10.61 | $38.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $22.00 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 477.0K | 174.4K |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 107.53 | ★ 171.84 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $2,606,898,000.00 |
| Revenue This Year | $24.54 | $0.78 |
| Revenue Next Year | $33.15 | $2.12 |
| P/E Ratio | ★ N/A | $31.93 |
| Revenue Growth | N/A | ★ 13.71 |
| 52 Week Low | $8.12 | $19.62 |
| 52 Week High | $16.68 | $40.39 |
| Indicator | DCTH | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 59.81 |
| Support Level | $10.55 | $30.79 |
| Resistance Level | $11.14 | N/A |
| Average True Range (ATR) | 0.49 | 2.12 |
| MACD | -0.09 | 0.34 |
| Stochastic Oscillator | 28.19 | 77.00 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.